Table 1.
Characteristics |
Discovery set (n = 30) |
Validation set (n = 122) |
|||||
EGC | AGC | BG | EGC | AGC | Control-1 | Control-2 | |
Number | 10 | 10 | 10 | 20 | 22 | 40 | 40 |
Age (yr) (mean ± SD) | 53.4 ± 2.6 | 57.0 ± 7.5 | 51.4 ± 10.0 | 63.3 ± 10.1 | 55.6 ± 13.9 | 50.2 ± 10.3 | 56.1 ± 11.3 |
Gender | |||||||
Male | 6 | 6 | 5 | 9 | 12 | 20 | 22 |
Female | 4 | 4 | 5 | 11 | 10 | 20 | 18 |
H. pylori | - | + | |||||
Pathology | |||||||
HGIN | 4 | 13 | |||||
Intramucosal cancer | 6 | 7 | |||||
TNM | |||||||
HGIN | 4 | 13 | |||||
T1a | 6 | 7 | |||||
… | |||||||
T4N2M0 | 2 | 2 | |||||
T4N3M0 | 4 | 14 | |||||
T4N3M1 | 4 | 6 |
EGC: Early gastric cancer; AGC: Advanced gastric cancer; BG: Benign gastritis; Control-1: Helicobacter pylori-negative gastritis; Control-2: Helicobacter pylori-positive atrophic gastritis; H. pylori: Helicobacter pylori; HGIN: High Grade Intraepithelial Neoplasia.